Avadel Pharmaceuticals (AVDL) Current Assets (2016 - 2022)
Historic Current Assets for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $113.2 million.
- Avadel Pharmaceuticals' Current Assets fell 4498.98% to $113.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $113.2 million, marking a year-over-year decrease of 4498.98%. This contributed to the annual value of $192.5 million for FY2021, which is 2693.6% down from last year.
- Avadel Pharmaceuticals' Current Assets amounted to $113.2 million in Q3 2022, which was down 4498.98% from $125.7 million recorded in Q2 2022.
- Avadel Pharmaceuticals' Current Assets' 5-year high stood at $281.7 million during Q3 2020, with a 5-year trough of $82.4 million in Q4 2019.
- Moreover, its 5-year median value for Current Assets was $160.7 million (2022), whereas its average is $172.3 million.
- Its Current Assets has fluctuated over the past 5 years, first plummeted by 5583.34% in 2019, then surged by 21980.34% in 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Current Assets (Quarter) stood at $124.9 million in 2018, then tumbled by 34.02% to $82.4 million in 2019, then surged by 219.8% to $263.5 million in 2020, then fell by 26.94% to $192.5 million in 2021, then tumbled by 41.18% to $113.2 million in 2022.
- Its Current Assets was $113.2 million in Q3 2022, compared to $125.7 million in Q2 2022 and $160.7 million in Q1 2022.